Leadership Overview
TriRx Pharmaceutical Services has 4 executives leading key functions including finance, information technology, operations, and human resources.
Driven by a commitment to advancing pharmaceutical solutions, TriRx Pharmaceutical Services supports customers' commercialization efforts across global markets with specialized development, manufacturing, and packaging services for both sterile and non-sterile products.
Driven by a commitment to advancing pharmaceutical solutions, TriRx Pharmaceutical Services supports customers' commercialization efforts across global markets with specialized development, manufacturing, and packaging services for both sterile and non-sterile products.
Leadership Roles at TriRx Pharmaceutical Services
Keith Lyon - Executive Vice President & Chief Financial Officer
Keith Lyon, the Executive Vice President & Chief Financial Officer at TriRx Pharmaceutical Services, directs all financial operations and strategic fiscal planning. Lyon oversees the company's financial health, managing budgets, forecasting, and resource allocation to support TriRx's expansion in both non-sterile and sterile product manufacturing. This leadership role ensures robust financial controls and drives investment strategies aligned with the company's mission to bring animal health injectables and packaging solutions to market. Lyon's oversight extends to managing capital expenditures and optimizing financial performance across facilities in Huntsville, Alabama, and Segré, France. The financial acumen provided by Keith Lyon is critical for sustaining TriRx's growth and supporting client commercialization efforts globally. Lyon also collaborates with other executive leaders to secure funding and manage investor relations, ensuring long-term financial stability and operational capacity for advanced pharmaceutical services.
James Scandura - Co-Founder & Director & Executive Vice President & Chief Operating Officer
James Scandura, the Co-Founder & Director & Executive Vice President & Chief Operating Officer at TriRx Pharmaceutical Services, directs all operational facets of the company's contract development and manufacturing services. Scandura oversees the execution of both non-sterile and sterile product manufacturing, including specialized animal health injectables and packaging solutions, ensuring adherence to the highest quality standards. This leadership role encompasses managing the day-to-day activities across TriRx's facilities in Huntsville, Alabama, and Segré, France, driving operational excellence and efficiency. James Scandura is pivotal in translating the company's strategic vision into tangible operational outcomes, supporting clients in their commercialization journeys. Scandura's deep involvement in operations ensures the seamless delivery of development, analytics, and manufacturing capabilities. The COO's strategic guidance optimizes production workflows and supply chain management, reinforcing TriRx's position as a premier partner for pharmaceutical companies seeking advanced market-ready solutions.
Scott Harris - Senior VP & Chief Information Officer
Scott Harris, the Senior VP & Chief Information Officer at TriRx Pharmaceutical Services, architects and executes the company's comprehensive information technology strategy. Harris is responsible for all digital infrastructure, data security, and technology innovation that underpins TriRx's specialized contract development and manufacturing operations. This includes managing systems for sterile and non-sterile product development, analytics, and packaging services, ensuring seamless integration across global sites in Huntsville, Alabama, and Segré, France. Scott Harris drives the implementation of advanced IT solutions that enhance operational efficiency and support client needs in bringing pharmaceutical products to market. The CIO's focus is on leveraging technology to streamline processes, protect sensitive client data, and enable scalable growth. Harris ensures that TriRx's technological capabilities remain at the forefront of the industry, supporting the company's commitment to delivering high-quality solutions and maintaining a competitive edge in the pharmaceutical services sector.
Richard Mark - Chief Human Resources Officer
Richard Mark, the Chief Human Resources Officer at TriRx Pharmaceutical Services, leads all human capital strategies and organizational development initiatives. Mark is responsible for cultivating a high-performance culture that supports TriRx's specialized operations in sterile and non-sterile product manufacturing, including animal health injectables and packaging. This role involves overseeing talent acquisition, employee relations, compensation, and benefits across TriRx's global footprint, including facilities in Huntsville, Alabama, and Segré, France. Richard Mark ensures that the company possesses the skilled workforce necessary to meet the complex demands of pharmaceutical development and manufacturing. Mark's strategic approach to HR management fosters employee engagement and retention, critical for maintaining the company's expertise and supporting client commercialization efforts. The CHRO's leadership is fundamental to building and sustaining a robust team dedicated to TriRx's mission of delivering advanced pharmaceutical solutions.
Explore Leadership Teams in Manufacturing
Founded in 1949 and Headquartered in Mumbai, India, Ipca Laboratories Limited (IPCA) is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
Company Leadership TK
KC

MA
Founded in 1998, Aldevron is a biotechnology privately held company that develops and manufactures plasmid DNA, proteins, enzymes, and antibodies. Aldevron is located in North Dakota.
Company Leadership MC
CT
LG
JM
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
MA

Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society. (Nasdaq: PCRX) is a provider of non-opioid pain management and regenerative health solutions manufacturing.
Company Leadership


